Characterization of ticlopidine-induced developmental and teratogenic defects in Xenopus embryos and human endothelial cells

Chemico-biological Interactions
Mi Seon ParkHyun-Shik Lee

Abstract

Ticlopidine is an anti-platelet drug that inhibits platelet aggregation via the functional alteration of platelet membranes. However, the mechanism underlying the adverse developmental effects of ticlopidine has not been clearly demonstrated. In this study, we evaluated the developmental toxicity and teratogenicity of ticlopidine on Xenopus laevis embryos and in human umbilical vein endothelial cells (HUVECs) using a frog embryo teratogenesis assay-Xenopus (FETAX) and blood and lymph vessel formation assays. Ticlopidine induced teratogenicity and inhibited growth, as evidenced by mortality rates and embryo lengths, respectively. Moreover, ticlopidine induced severe hemorrhages and inhibited both blood and lymph vessel formation by modulating the expression of xMsr and Prox1 in Xenopus embryos. Additionally, Nkx2.5 and Cyl104 levels were perturbed by ticlopidine exposure, and more extensive aberrations were observed in the liver and heart using whole-mount in situ hybridization. In addition, ticlopidine reduced branching in HUVECs by blocking the effect of the angiogenic vascular endothelial growth factor (VEGF). Results from this study suggest that ticlopidine is a developmental toxicant and teratogen and therefore this is a st...Continue Reading

References

Oct 12, 1999·Circulation·M J Quinn, D J Fitzgerald
Jun 3, 2004·Best Practice & Research. Clinical Haematology·Alan K Jacobson
Jun 3, 2005·Nature Reviews. Drug Discovery·Neil Kaplowitz
Nov 5, 2005·Environmental Toxicology and Chemistry·Robert A Hoke, Gerald T Ankley
May 17, 2008·Journal of Vascular Surgery·Osamu IidaSeiki Nagata
Jun 17, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Bibek Sharma, Reynaldo Patiño
Aug 2, 2008·Chemosphere·Antonella FranchiniEnzo Ottaviani
Oct 3, 2008·Biology of the Cell·Yong Chen, Xinmin Cao
Oct 31, 2008·Journal of Vascular Surgery·Shiva DindyalConstantinos Kyriakides
Dec 18, 2010·International Journal of Molecular Medicine·Juan WangYi-Qing Yang
Feb 25, 2011·Chemosphere·Shawna NationsGeorge P Cobb
May 18, 2011·Nanotoxicology·Renato BacchettaParide Mantecca
Sep 21, 2011·Journal of Visualized Experiments : JoVE·Ralph A FrancesconeRong Shao
Apr 13, 2012·The Journal of Pharmacology and Experimental Therapeutics·Yu-Jing BaiXiao-Xin Li
Jan 9, 2013·Development, Growth & Differentiation·Yuki Sato
Mar 19, 2013·Toxicology·Swarna MaseneniStephan Krähenbühl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.